LINDSEY WALDEN: Open Payments
NPI 1154871549 · OOLTEWAH, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$947 in 52 payments from 16 companies in 2025. Trend: 2023 $887 · 2024 $1,170 · 2025 $947
Food & beverage: $947
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $232 |
| ABBVIE INC. | 12 | $166 |
| Axsome Therapeutics, Inc. | 5 | $143 |
| PFIZER INC. | 3 | $57 |
| AstraZeneca Pharmaceuticals LP | 3 | $53 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $44 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $38 |
| Inspire Medical Systems, Inc. | 2 | $34 |
| GlaxoSmithKline, LLC. | 2 | $32 |
| Globus Medical, Inc. | 1 | $30 |
Products named: Auvelity, VRAYLAR, Rybelsus, Wegovy, Ozempic, QULIPTA, TRINTELLIX, XIFAXAN.
Industry payments across TN — which companies pay providers there.
